Silenor
NDC 42847-103, doxepin hydrochloride, tablet, from Currax Pharmaceuticals LLC.
- Product NDC
- 42847-103
- Status
- Listed
- Labeler
- Currax Pharmaceuticals LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022036
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42847-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXEPIN HYDROCHLORIDE3 mg/1
Pharmacologic classes
Tricyclic Antidepressant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42847-103-03 | 42847010303 | 30 TABLET in 1 BLISTER PACK (42847-103-03) |
| 42847-103-10 | 42847010310 | 100 TABLET in 1 BOTTLE (42847-103-10) |
| 42847-103-30 | 42847010330 | 30 TABLET in 1 BOTTLE (42847-103-30) |
| 42847-103-50 | 42847010350 | 500 TABLET in 1 BOTTLE (42847-103-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1bec1223-5239-4eb6-a9e8-62444106d2c0
Use it
Look up 42847-103 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42847-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42847-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.